Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Legacy Pharmaceutical Packaging acquires blister production lines from McKesson RxPak

By Chris Newmarker | April 22, 2020

Legacy Pharmaceutical Packaging blixters

Pile of tablets pill in blister packaging. [Image courtesy of Legacy Pharmaceutical Packaging]

Legacy Pharmaceutical Packaging (Earth City, Mo.) announced this month that it has purchased three high-speed blistering and cartoning lines from McKesson RxPak’s production facility in Memphis, Tenn.

Financial terms of the deal were undisclosed.

The infrastructure acquisition — which includes serialization and aggregation capabilities — nearly doubles Legacy’s total blister production capacity, which is presently half a billion packs per year.

In a separate equipment investment, Legacy this summer will also add an additional new high-speed bottling line, bringing the contract packager’s bottling capacity to some 600 million units per year. Additionally, the company recently incorporated two new pouching machines to help meet growing demand for tablet and capsule filling applications.

“This infrastructure investment is a natural evolution of the expansion plans Legacy adopted several years ago, starting with a 100,000-square-foot expansion in 2017 that added both production capabilities and warehousing capacity providing a total of 300,000 square feet,” said David Spence, CEO of Legacy Pharmaceutical Packaging. “Considering both recent growth, and that we anticipate more U.S. base production moving forward, this was the right time to continue in a way that makes Legacy an even more versatile, dynamic and turnkey packaging partner.”

Tell Us What You Think! Cancel reply

Related Articles Read More >

Pfizer logo
Pfizer seeks to comply with voluntary Net-Zero Standard by 2040
Cambridge Pharma launches with UK plant in Cambridge Research Park
Entegris logo
Entegris opens Life Sciences Technology Center in Massachusetts
sustainability
How pharma can optimize for right-the-first-time drug manufacturing and sustainability

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards